Phage Therapy Market By Size, Share, Trends, Growth, Forecast 2027

Report Description

The global phage therapy market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of foodborne diseases, anti-biotic infections, and extensive research and development. Phages, also known as bacteriophages, are viruses that only kill and selectively target bacteria. They are the most common biological entities found in nature, effectively fighting, and destroying multi-drug-resistant bacteria. They are used to treat or stop bacterial infections in patients’ bodies. The other factors supporting the market’s growth are, the increasing application of bacteriophage across the food and beverage industry, increasing government investments, rising awareness among the masses, and technological advancements.

High Prevalence Rate of Foodborne Diseases and Anti-Biotic Infections

The rise in the prevalence rate of foodborne diseases and anti-biotic infections across the globe is expected to enhance the market’s growth. Foodborne infections are caused by rotten food, as pathogenic bacteria and viruses are present in them. Bacteriophages are extremely specific to target bacteria. Its usage targets a specific bacterial species and significantly reduces off-target effects on the microbiome or human patient, as bacteriophages do not directly affect human cells. According to the WHO, in 2019, forecasted that about 600 million people will become ill and 420,000 will die because of contaminated food resulting in the loss of 33 million healthy life years. Also, according to the Centers for Disease Control and Prevention (CDC), in 2019, approximately 2 million people in the United States will contract an antibiotic-resistant infection, with at least 23,000 people dying every year.

Increasing Investment

Heavy investments to support phage therapy by the government is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government and lead companies across the globe are investing in clinical trials and R&D Activities, which is propelling the growth of the market. For instance, in 2016, the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, was granted US$ 5 Mn for 24 research projects to develop advanced therapies such as bacteriophage therapy and others for the treatment of bacterial infections.

Emergence of e-Commerce

Emergence of e-Commerce is bolstering the growth of the market. Several biotech market players are starting to set up online pharmacies of bacteriophage preparations to make phages and phage therapies available across the globe. For instance, in 2020, Ridgeway, a Digital agency, launched a new e-Commerce website for Optibac probiotics, to build on customer compliance and repeat purchase of phage therapy supplements.

Download Free Sample Report

Market Segmentation

The global phage therapy market is segmented into bacteria type, products, application, and company. Based on bacteria type, the market is divided into salmonella, bacteriophage, streptococcus, E.coli, and others. Based on products, the market is divided into oral consumption, external consumption, and surgical treatment. Based on application, the market is segmented into human medicines, veterinary sciences, food & beverage, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of foodborne diseases and anti-biotic infections in the country.

Market Players

Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc are some of the leading companies operating in the market.

Attribute	Details
Base Year	2021
Historic Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends
Segments covered	· Bacteria Type · Products · Application · Company
Regional scope	North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa
Key companies profiled	Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global phage therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Phage Therapy Market, By Bacterial Type:

Salmonella
Bacteriophage
Streptococcus
E.Coli
Others

· Phage Therapy Market, By Products:

Oral Consumption
External Consumption
Surgical Treatment

· Phage Therapy Market, By Application:

Human Medicines
Veterinary Sciences
Food & Beverage
Others

· Phage Therapy Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
Japan
Australia
South Korea

Europe & CIS

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Phage Therapy Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Phage Therapy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Phage Therapy Market

5. Voice of Customer

6. Clinical Trials Analysis

7. Global Phage Therapy Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others)

7.2.2. By Product (Oral Consumption, External Consumption, Surgical Treatment)

7.2.3. By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others)

7.2.4. By Company (2021)

7.2.5. By Region

7.3. Market Map

8. North America Phage Therapy Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Bacteria Type

8.2.2. By Product

8.2.3. By Application

8.2.4. By Country

8.3. North America: Country Analysis

8.3.1. United States Phage Therapy Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Bacteria Type

8.3.1.2.2. By Product

8.3.1.2.3. By Application

8.3.2. Mexico Phage Therapy Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Bacteria Type

8.3.2.2.2. By Product

8.3.2.2.3. By Application

8.3.3. Canada Phage Therapy Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Bacteria Type

8.3.3.2.2. By Product

8.3.3.2.3. By Application

9. Europe Phage Therapy Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Bacteria Type

9.2.2. By Product

9.2.3. By Application

9.2.4. By Country

9.3. Europe: Country Analysis

9.3.1. France Phage Therapy Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Bacteria Type

9.3.1.2.2. By Product

9.3.1.2.3. By Application

9.3.2. Germany Phage Therapy Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Bacteria Type

9.3.2.2.2. By Product

9.3.2.2.3. By Application

9.3.3. United Kingdom Phage Therapy Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Bacteria Type

9.3.3.2.2. By Product

9.3.3.2.3. By Application

9.3.4. Italy Phage Therapy Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Bacteria Type

9.3.4.2.2. By Product

9.3.4.2.3. By Application

9.3.5. Spain Phage Therapy Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Bacteria Type

9.3.5.2.2. By Product

9.3.5.2.3. By Application

10. Asia-Pacific Phage Therapy Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Bacteria Type

10.2.2. By Product

10.2.3. By Application

10.2.4. By Country

10.3. Asia-Pacific: Country Analysis

10.3.1. China Phage Therapy Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Bacteria Type

10.3.1.2.2. By Product

10.3.1.2.3. By Application

10.3.2. India Phage Therapy Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Bacteria Type

10.3.2.2.2. By Product

10.3.2.2.3. By Application

10.3.3. Japan Phage Therapy Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Bacteria Type

10.3.3.2.2. By Product

10.3.3.2.3. By Application

10.3.4. South Korea Phage Therapy Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Bacteria Type

10.3.4.2.2. By Product

10.3.4.2.3. By Application

10.3.5. Australia Phage Therapy Market Outlook

10.3.5.1. Market Size & Forecast

10.3.5.1.1. By Value

10.3.5.2. Market Share & Forecast

10.3.5.2.1. By Bacteria Type

10.3.5.2.2. By Product

10.3.5.2.3. By Application

11. South America Phage Therapy Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Bacteria Type

11.2.2. By Product

11.2.3. By Application

11.2.4. By Country

11.3. South America: Country Analysis

11.3.1. Brazil Phage Therapy Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Bacteria Type

11.3.1.2.2. By Product

11.3.1.2.3. By Application

11.3.2. Argentina Phage Therapy Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Bacteria Type

11.3.2.2.2. By Product

11.3.2.2.3. By Application

11.3.3. Colombia Phage Therapy Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Bacteria Type

11.3.3.2.2. By Product

11.3.3.2.3. By Application

12. Middle East and Africa Phage Therapy Market Outlook

12.1. Market Size & Forecast

12.1.1. By Value

12.2. Market Share & Forecast

12.2.1. By Bacteria Type

12.2.2. By Product

12.2.3. By Application

12.2.4. By Country

12.3. MEA: Country Analysis

12.3.1. South Africa Phage Therapy Market Outlook

12.3.1.1. Market Size & Forecast

12.3.1.1.1. By Value

12.3.1.2. Market Share & Forecast

12.3.1.2.1. By Bacteria Type

12.3.1.2.2. By Product

12.3.1.2.3. By Application

12.3.2. Saudi Arabia Phage Therapy Market Outlook

12.3.2.1. Market Size & Forecast

12.3.2.1.1. By Value

12.3.2.2. Market Share & Forecast

12.3.2.2.1. By Bacteria Type

12.3.2.2.2. By Product

12.3.2.2.3. By Application

12.3.3. UAE Phage Therapy Market Outlook

12.3.3.1. Market Size & Forecast

12.3.3.1.1. By Value

12.3.3.2. Market Share & Forecast

12.3.3.2.1. By Bacteria Type

12.3.3.2.2. By Product

12.3.3.2.3. By Application

12.3.4. Egypt Phage Therapy Market Outlook

12.3.4.1. Market Size & Forecast

12.3.4.1.1. By Value

12.3.4.2. Market Share & Forecast

12.3.4.2.1. By Bacteria Type

12.3.4.2.2. By Product

12.3.4.2.3. By Application

12.3.5. Turkey Phage Therapy Market Outlook

12.3.5.1. Market Size & Forecast

12.3.5.1.1. By Value

12.3.5.2. Market Share & Forecast

12.3.5.2.1. By Bacteria Type

12.3.5.2.2. By Product

12.3.5.2.3. By Application

13. Market Dynamics

13.1. Drivers

13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

15.1. Armata Pharmaceuticals, Inc.

15.2. iNtODEWORLD, Inc.

15.3. Phage International, Inc.

15.4. Fixed-Phage Limited

15.5. OCUS BIOSCIENCES, INC.

15.6. Intralytix, Inc

15.7. PhagoMed Biopharma GmbH

15.8. PHAGELUX, INC.

15.9. Pherecydes Pharma SADIR

15.10. Adaptive Phage Therapeutics Inc.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the global phage therapy market?

Growing incidences of foodborne diseases and anti-biotic infections, and extensive research and development are driving the demand for the global phage therapy market.

Who are the top players operating in the global phage therapy market?

Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc are the key players operating in the global Phage Therapy market.

What are the key factors hampering growth for the global phage therapy market?

The high cost of bacteriophages therapy is one of the prime factors restraining the growth of the global bacteriophage therapy market. Expensive clinical testing and high risk of product failure for drug development are factors restraining market growth. Physicians need special training to correctly prescribe and use phages. Thus, lack of skilled professionals can hamper the growth of the bacteriophages therapy market.